Solventum Corporation announced the pricing of a secondary offering of 8,800,000 shares of its common stock, expected to generate approximately $648 million in gross proceeds for 3M Company, the selling shareholder. Solventum itself will not receive any proceeds from this offering. The transaction, managed by underwriters Goldman Sachs & Co. LLC and BofA Securities, is anticipated to close on or around August 15, 2025, subject to customary closing conditions. The shares are being offered under the company's shelf registration statement on Form S-3, which became effective upon filing with the SEC. Investors are encouraged to review the preliminary prospectus supplement and accompanying prospectus for more detailed information.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.